ProQR Therapeutics (PRQR) Change in Working Capital (2013 - 2022)

ProQR Therapeutics' Change in Working Capital history runs 10 years deep, the most recent figure standing at $3.5 million for Q3 2022.

• In Q3 2022, Change in Working Capital fell 47.64% year-over-year to $3.5 million; the TTM figure through Sep 2022 stood at $3.5 million (down 47.64% YoY), while the FY2023 annual figure was -$52.7 million, down 11554.26% from the prior year.
• Change in Working Capital came in at $3.5 million for Q3 2022 at ProQR Therapeutics, up from -$3.5 million in the prior quarter.
• In the past five years, Change in Working Capital ranged from a high of $28.6 million in Q4 2021 to a low of -$6.5 million in Q4 2020.
• A 5-year average of $1.3 million and a median of $1149.9 in 2018 frame the typical range for Change in Working Capital.
• Across the five-year window, Change in Working Capital jumped 133420.71% in 2019 and plunged 47182.62% in 2021, its largest moves.
• ProQR Therapeutics' Change in Working Capital stood at $1478.1 in 2018, then surged by 133420.71% to $2.0 million in 2019, then sank by 430.7% to -$6.5 million in 2020, then soared by 538.11% to $28.6 million in 2021, then tumbled by 87.78% to $3.5 million in 2022.
• According to Business Quant data, Change in Working Capital over the past three periods registered $3.5 million, -$3.5 million, and -$4.5 million for Q3 2022, Q2 2022, and Q1 2022 respectively.

Peer Comparison